{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:28:05Z","timestamp":1783736885064,"version":"3.55.0"},"reference-count":69,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre, Poland","doi-asserted-by":"publisher","award":["Sonata Bis 2019\/34\/E\/NZ7\/00056"],"award-info":[{"award-number":["Sonata Bis 2019\/34\/E\/NZ7\/00056"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Olaparib is a poly (ADP-ribose) polymerase inhibitor (PARPi) that inhibits PARP1\/2, leading to replication-induced DNA damage that requires homologous recombination repair. Olaparib is often insufficient to treat BRCA-mutated (BRCAMUT) and BRCA wild-type (BRCAWT) high-grade serous ovarian carcinomas (HGSOCs). We examined the short-term (up to 48 h) efficacy of PARPi treatment on a DNA damage response pathway mediated by ATR and CHK1 kinases in BRCAMUT (PEO-1) and BRCAWT (SKOV-3 and OV-90) cells. The combination of ATRi\/CHK1i with PARPi was not more cytotoxic than ATR and CHK1 monotherapy. The combination of olaparib with inhibitors of the ATR\/CHK1 pathway generated chromosomal abnormalities, independent on BRCAMUT status of cells and formed of micronuclei (MN). However, the beneficial effect of the PARPi:ATRi combination on MN was seen only in the PEO1 BRCAMUT line. Monotherapy with ATR\/CHK1 inhibitors reduced BrdU incorporation due to a slower rate of DNA synthesis, which resulted from elevated levels of replication stress, while simultaneous blockade of PARP and ATR caused beneficial effects only in OV-90 cells. Inhibition of ATR\/CHK1 increased the formation of double-strand breaks as measured by increased \u03b3H2AX expression at collapsed replication forks, resulting in increased levels of apoptosis. Our findings indicate that ATR and CHK1 inhibitors provoke premature mitotic entry, leading to genomic instability and ultimately cell death.<\/jats:p>","DOI":"10.3390\/cells11121889","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T10:25:12Z","timestamp":1654856712000},"page":"1889","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous BRCAMUT and BRCAWT Ovarian Cancer Cells"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2363-7827","authenticated-orcid":false,"given":"Patrycja","family":"Gralewska","sequence":"first","affiliation":[{"name":"Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3475-441X","authenticated-orcid":false,"given":"Arkadiusz","family":"Gajek","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-3391","authenticated-orcid":false,"given":"Dorota","family":"Rybaczek","sequence":"additional","affiliation":[{"name":"Department of Cytophysiology, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3439-9032","authenticated-orcid":false,"given":"Agnieszka","family":"Marczak","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4170-1693","authenticated-orcid":false,"given":"Aneta","family":"Rogalska","sequence":"additional","affiliation":[{"name":"Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Ahmed, N., Kadife, E., Raza, A., Short, M., Jubinsky, P.T., and Kannourakis, G. (2020). Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods. Cells, 9.","DOI":"10.3390\/cells9030719"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Beaufort, C.M., Helmijr, J.C., Piskorz, A.M., Hoogstraat, M., Ruigrok-Ritstier, K., Besselink, N., Murtaza, M., Van, I.W.F., Heine, A.A., and Smid, M. (2014). Ovarian cancer cell line panel (OCCP): Clinical importance of in vitro morphological subtypes. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103988"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e450s","DOI":"10.6061\/clinics\/2018\/e450s","article-title":"Homologous recombination deficiency in ovarian cancer: A review of its epidemiology and management","volume":"73","author":"Fogace","year":"2018","journal-title":"Clinics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1200\/EDBK_288015","article-title":"PARP Inhibitors for Ovarian Cancer: Current Indications, Future Combinations, and Novel Assets in Development to Target DNA Damage Repair","volume":"40","author":"Konstantinopoulos","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.genet.38.072902.092448","article-title":"Repair and genetic consequences of endogenous DNA base damage in mammalian cells","volume":"38","author":"Barnes","year":"2004","journal-title":"Annu. Rev. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ito, S., Murphy, C.G., Doubrovina, E., Jasin, M., and Moynahan, M.E. (2016). PARP Inhibitors in Clinical Use Induce Genomic Instability in Normal Human Cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159341"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e20190070","DOI":"10.1590\/1678-4685-gmb-2019-0070","article-title":"Persistent double strand break accumulation does not precede cell death in an Olaparib-sensitive BRCA-deficient colorectal cancer cell model","volume":"43","author":"Paviolo","year":"2019","journal-title":"Genet. Mol. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Nussenzweig","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3389\/fonc.2020.00958","article-title":"Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer","volume":"10","author":"Huang","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gralewska, P., Gajek, A., Marczak, A., Mikula, M., Ostrowski, J., Sliwinska, A., and Rogalska, A. (2020). PARP Inhibition Increases the Reliance on ATR\/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249715"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/MCB.21.13.4129-4139.2001","article-title":"ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1","volume":"21","author":"Zhao","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00418-011-0793-3","article-title":"Premature chromosome condensation induced by caffeine, 2-aminopurine, staurosporine and sodium metavanadate in S-phase arrested HeLa cells is associated with a decrease in Chk1 phosphorylation, formation of phospho-H2AX and minor cytoskeletal rearrangements","volume":"135","author":"Rybaczek","year":"2011","journal-title":"Histochem. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/2211-5463.12206","article-title":"The G2 checkpoint-a node-based molecular switch","volume":"7","author":"Bockaj","year":"2017","journal-title":"FEBS Open Bio"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15981","DOI":"10.1038\/ncomms15981","article-title":"Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells","volume":"8","author":"Schoonen","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/CCO.0000000000000016","article-title":"Putting poly (ADP-ribose) polymerase and other DNA repair inhibitors into clinical practice","volume":"25","author":"Helleday","year":"2013","journal-title":"Curr. Opin. Oncol."},{"key":"ref_16","first-page":"943","article-title":"Evaluation of a Tetrazolium-Based Semiautomated Colorimetric Assay\u2014Assessment of Radiosensitivity","volume":"47","author":"Carmichael","year":"1987","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2053-6844-1-2","article-title":"Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines","volume":"1","author":"Grace","year":"2014","journal-title":"Gynecol. Oncol. Res. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0014-4827(58)90067-3","article-title":"Nigrosin as a dye for differentiating live and dead ascites cells","volume":"15","author":"Kaltenbach","year":"1958","journal-title":"Exp. Cell Res."},{"key":"ref_19","first-page":"485","article-title":"Analysis of the cell cycle and a method employing synchronized cells for study of protein expression at various stages of the cell cycle","volume":"69","author":"Uzbekov","year":"2004","journal-title":"Biochemistry"},{"key":"ref_20","first-page":"75","article-title":"A method of estimation of the cell doubling time on basis of the cell culture monitoring data","volume":"28","author":"Zychowicz","year":"2008","journal-title":"Biocybern. Biomed. Eng."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"152847","DOI":"10.1016\/j.phymed.2019.152847","article-title":"Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells","volume":"61","author":"Rogalska","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1038\/s41598-020-61436-x","article-title":"Chemical modification of melphalan as a key to improving treatment of haematological malignancies","volume":"10","author":"Gajek","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tiv.2012.09.006","article-title":"Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B","volume":"27","author":"Rogalska","year":"2013","journal-title":"Toxicol. In Vitr."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gralewska, P., Gajek, A., Marczak, A., and Rogalska, A. (2021). Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910557"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.183.4122.330","article-title":"Spheroid chromatin units (v bodies)","volume":"183","author":"Olins","year":"1974","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1083\/jcb.83.2.403","article-title":"Involvement of histone H1 in the organization of the nucleosome and of the salt-dependent superstructures of chromatin","volume":"83","author":"Thoma","year":"1979","journal-title":"J. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00412-007-0109-5","article-title":"Visualizing the dynamics of chromosome structure formation coupled with DNA replication","volume":"116","author":"Gotoh","year":"2007","journal-title":"Chromosoma"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bcp.2016.09.013","article-title":"Pharmacological inhibition of arginine and lysine methyltransferases induces nuclear abnormalities and suppresses angiogenesis in human endothelial cells","volume":"121","author":"Balcerczyk","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fgene.2013.00131","article-title":"Micronuclei in genotoxicity assessment: From genetics to epigenetics and beyond","volume":"4","author":"Luzhna","year":"2013","journal-title":"Front. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nprot.2007.77","article-title":"Cytokinesis-block micronucleus cytome assay","volume":"2","author":"Fenech","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"743073","DOI":"10.3389\/fphar.2021.743073","article-title":"Update on Poly ADP-Ribose Polymerase Inhibitors in Ovarian Cancer with Non-BRCA Mutations","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_32","unstructured":"FDA (2022, June 02). FDA Approved Olaparib (LYNPARZA, AstraZeneca Pharmaceuticals LP) for the Maintenance Treatment of Adult Patients with Deleterious or Suspected Deleterious Germline or Somatic BRCA-Mutated (gBRCAm or sBRCAm) Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Who Are in Complete or Partial Response to First-Line Platinum-Based, Available online: https:\/\/www.fda.gov\/drugs\/fda-approved-olaparib-lynparza-astrazeneca-pharmaceuticals-lp-maintenance-treatment-adult-patients."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1158\/1078-0432.CCR-17-1337","article-title":"FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA Mutation\u2013Associated Advanced Ovarian Cancer","volume":"23","author":"Balasubramaniam","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"CT232","DOI":"10.1158\/1538-7445.AM2019-CT232","article-title":"Abstract CT232: Phase I combination study of the CHK1 inhibitor prexasertib (LY2606368) and olaparib in patients with high-grade serous ovarian cancer and other advanced solid tumors","volume":"79","author":"Do","year":"2019","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gomez, M.K., Illuzzi, G., Colomer, C., Churchman, M., Hollis, R.L., O\u2019Connor, M.J., Gourley, C., Leo, E., and Melton, D.W. (2020). Identifying and Overcoming Mechanisms of PARP Inhibitor Resistance in Homologous Recombination Repair-Deficient and Repair-Proficient High Grade Serous Ovarian Cancer Cells. Cancers, 12.","DOI":"10.3390\/cancers12061503"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11523-021-00842-1","article-title":"Olaparib: A Review as First-Line Maintenance Therapy in Advanced Ovarian Cancer","volume":"16","author":"Paik","year":"2021","journal-title":"Target Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/cdd.2008.47","article-title":"Death through a tragedy: Mitotic catastrophe","volume":"15","author":"Vakifahmetoglu","year":"2008","journal-title":"Cell Death Differ."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1038\/s41388-020-1328-y","article-title":"Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells","volume":"39","author":"Lloyd","year":"2020","journal-title":"Oncogene"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Miyasaka, A., Oda, K., Ikeda, Y., Wada-Hiraike, O., Kashiyama, T., Enomoto, A., Hosoya, N., Koso, T., Fukuda, T., and Inaba, K. (2014). Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-179"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Dubois, C., Martin, F., Hassel, C., Magnier, F., Daumar, P., Aubel, C., Guerder, S., Mounetou, E., Penault-Lorca, F., and Bamdad, M. (2019). Low-Dose and Long-Term Olaparib Treatment Sensitizes MDA-MB-231 and SUM1315 Triple-Negative Breast Cancers Spheroids to Fractioned Radiotherapy. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010064"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2125.2006.02713.x","article-title":"Drug development in oncology: Classical cytotoxics and molecularly targeted agents","volume":"62","author":"Kummar","year":"2006","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13059-019-1867-0","article-title":"Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents","volume":"20","author":"Poti","year":"2019","journal-title":"Genome Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.celrep.2014.10.060","article-title":"Activation of DNA damage response signaling by condensed chromatin","volume":"9","author":"Burgess","year":"2014","journal-title":"Cell Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1126\/science.1159051","article-title":"Activation of the cellular DNA damage response in the absence of DNA lesions","volume":"320","author":"Soutoglou","year":"2008","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Nalabothula, N., Al-jumaily, T., Eteleeb, A.M., Flight, R.M., Xiaorong, S., Moseley, H., Rouchka, E.C., and Fondufe-Mittendorf, Y.N. (2015). Genome-Wide Profiling of PARP1 Reveals an Interplay with Gene Regulatory Regions and DNA Methylation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135410"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.molmed.2021.04.010","article-title":"Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance","volume":"27","author":"Andronikou","year":"2021","journal-title":"Trends Mol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gde.2010.06.001","article-title":"The roles of PARP1 in gene control and cell differentiation","volume":"20","author":"Ji","year":"2010","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.celrep.2014.07.024","article-title":"A macrohistone variant links dynamic chromatin compaction to BRCA1-dependent genome maintenance","volume":"8","author":"Khurana","year":"2014","journal-title":"Cell Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1083\/jcb.201001048","article-title":"The NuRD chromatin-remodeling complex regulates signaling and repair of DNA damage","volume":"190","author":"Smeenk","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/onc.2017.40","article-title":"PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma","volume":"36","author":"Colicchia","year":"2017","journal-title":"Oncogene"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1535-7163.MCT-16-0239","article-title":"Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei","volume":"16","author":"Dillon","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1038\/s41467-018-05031-9","article-title":"Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance","volume":"9","author":"Michelena","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/1878-0261.12573","article-title":"Premature mitotic entry induced by ATR inhibition potentiates olaparib inhibition-mediated genomic instability, inflammatory signaling, and cytotoxicity in BRCA2-deficient cancer cells","volume":"13","author":"Schoonen","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_54","first-page":"771","article-title":"Cell Death Response to DNA Damage","volume":"92","author":"Wang","year":"2019","journal-title":"Yale J. Biol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.dnarep.2017.11.004","article-title":"Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1\/2\/3 inhibitor olaparib","volume":"61","author":"Gravells","year":"2018","journal-title":"DNA Repair"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.aap9346","article-title":"An intrinsic S\/G2 checkpoint enforced by ATR","volume":"361","author":"Saldivar","year":"2018","journal-title":"Science"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1007\/s00018-013-1307-3","article-title":"Checkpoint kinase 1 in DNA damage response and cell cycle regulation","volume":"70","author":"Patil","year":"2013","journal-title":"Cell Mol. Life Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/S0960-9822(02)01226-5","article-title":"DNA damage during mitosis in human cells delays the metaphase\/anaphase transition via the spindle-assembly checkpoint","volume":"12","author":"Mikhailov","year":"2002","journal-title":"Curr. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bcp.2019.03.028","article-title":"Mitotic functions of poly(ADP-ribose) polymerases","volume":"167","author":"Slade","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1158\/0008-5472.CAN-18-2480","article-title":"Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress","volume":"79","author":"Young","year":"2019","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-019-1490-7","article-title":"MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1","volume":"39","author":"Vescarelli","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1038\/s41467-019-10460-1","article-title":"Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence","volume":"10","author":"Fleury","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"zcab018","DOI":"10.1093\/narcan\/zcab018","article-title":"Targeting IDH1\/2 mutant cancers with combinations of ATR and PARP inhibitors","volume":"3","author":"Sule","year":"2021","journal-title":"NAR Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1158\/0008-5472.CAN-13-0110","article-title":"ATR Inhibition Broadly Sensitizes Ovarian Cancer Cells to Chemotherapy Independent of BRCA Status","volume":"73","author":"Huntoon","year":"2013","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"103931","DOI":"10.18632\/oncotarget.21879","article-title":"PARP inhibition causes premature loss of cohesion in cancer cells","volume":"8","author":"Kukolj","year":"2017","journal-title":"Oncotarget"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Southgate, H.E.D., Chen, L., Tweddle, D.A., and Curtin, N.J. (2020). ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms. Cancers, 12.","DOI":"10.3390\/cancers12051095"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1158\/1078-0432.CCR-16-2273","article-title":"Targeting the ATR\/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models","volume":"23","author":"Kim","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1158\/1078-0432.CCR-12-3748","article-title":"Sensitization of pancreatic cancer to chemoradiation by the Chk1 inhibitor MK8776","volume":"19","author":"Engelke","year":"2013","journal-title":"Clin. Cancer Res."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/12\/1889\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:27:40Z","timestamp":1760138860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/12\/1889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":69,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["cells11121889"],"URL":"https:\/\/doi.org\/10.3390\/cells11121889","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]}}}